New Drug Baxdrostat Offers 24-Hour Relief for Resistant High Blood Pressure
High blood pressure affects millions worldwide and often resists standard treatments. Now, a new drug called Baxdrostat could change that. The promising medication has shown strong results in helping people with treatment-resistant hypertension.
A new way to control pressure
Baxdrostat targets aldosterone, a hormone that regulates salt and water balance. Too much aldosterone can raise blood pressure. Traditional drugs block its effects, but Baxdrostat works at the source. It blocks the enzyme that makes aldosterone, helping lower blood pressure more effectively.
In a large international trial, nearly 800 people with uncontrolled hypertension took Baxdrostat or a placebo for 12 weeks. Those on 2 mg Baxdrostat saw their systolic blood pressure drop by an average of 15.7 mmHg. This effect stayed consistent throughout the day and night, even during early morning hours when the risk of heart attack and stroke is highest. The treatment was also well tolerated, with no major safety issues reported.
What this means for patients
Experts call these findings a major breakthrough. For many patients who take several drugs with little success, a once-daily pill that offers round-the-clock protection could be life-changing. According to the British Heart Foundation, controlling blood pressure can greatly reduce the risk of heart disease, stroke, and kidney failure.
AstraZeneca plans to seek regulatory approval by late 2025. However, researchers note that long-term results and global accessibility will be key. Still, Baxdrostat marks an exciting step forward in tackling one of the world’s toughest health challenges.
